Fri, Jul 25, 2014, 11:44 PM EDT - U.S. Markets closed


% | $
Click the to save as a favorite.

Oncolytics Biotech Inc. Message Board

starsearcher40 1 post  |  Last Activity: Jul 9, 2014 10:57 AM Member since: Jun 10, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • starsearcher40 by starsearcher40 Jul 9, 2014 10:57 AM Flag

    I don't post on this Board too often as I've found following the V2 board to be a much more fruitful discussion in general. And even there, I've been particularly silent as the trading patterns were relentlessly dismal for a very long time. Those patterns have now changed, and it is worth noting. So here then, a rare foray back into the jungle of the "regular" ONCY Board:

    Here are the posts (2 in total) that I've made on the V2 board:

    1) PRE-Market comment on share price:

    Just a comment for the fun of it. Based on the technical indicators that I use, I'm anticipating a particularly strong upside day for Onc/y We'll see what comes..

    2) Additional Commentary (mid-morning):

    There is some clutter in the $1.80 level (ONCY), but I don't think this is going to pose any problem as far as resistance goes. Within the context of a badly beaten down stock, the duration of the downswing, the dry nature of the way the stock is trading, and impending news, I see no issue whatsoever with the stock moving up back to the $2.40 level in the very near term. Personally, I still think even that price is vastly undervalued for what the share price should be (all things considered), but it at least serves my own eyes as a short term price target.

    As for the way the stock is behaving so today, I like everything I'm seeing. -All indications of a healthy run up to come.

1.40-0.03(-2.10%)Jul 25 3:59 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.